San Diego, California (Newsfile Corp. - May 10, 2022) - Mycrodose Therapeutics showed the ability to synthesize and stabilize psilocin in their laboratory for use in their IP-protected drug delivery
San Diego, California (Newsfile Corp. - March 31, 2022) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company specializing in the development of advanced drug delivery technologies
DEA approval allows Mycrodose Therapeutics to become the first vertically integrated US Pharmaceutical company utilizing psilocybin-based psychedelic medicine. Approval also allows Mycrodose the ability
San Diego, California (PRWEB) August 20, 2021 Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug